Goldman Sachs Group Inc Akoya Biosciences, Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 173,441 shares of AKYA stock, worth $223,738. This represents 0.0% of its overall portfolio holdings.
Number of Shares
173,441
Previous 99,780
73.82%
Holding current value
$223,738
Previous $138,000
63.04%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding AKYA
# of Institutions
54Shares Held
13MCall Options Held
0Put Options Held
14K-
Blue Water Life Science Advisors, LP Larkspur, CA4.7MShares$6.06 Million4.83% of portfolio
-
Oddo Bhf Asset Management Sas Paris, I01.89MShares$2.44 Million0.1% of portfolio
-
Black Rock Inc. New York, NY1.5MShares$1.94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.19MShares$1.54 Million0.0% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX671KShares$865,5901.49% of portfolio
About Akoya Biosciences, Inc.
- Ticker AKYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,892,300
- Market Cap $48.9M
- Description
- Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...